Chaired By:

Michael W. Washabaugh, PhD
Immunova Therapeutics

Scientific Advisory Board:

Maureen A. Costello, PhD
Costello Consulting, LLC

Mark F. Witcher, PhD
Exyte

Martin Vanderlaan, PhD

Topics

  • Reducing Production Costs
  • Transients to Expedite Stable Cell Lines
  • Securing Additional Capacity
  • Accelerating Product Development
  • Front Loading Analytical Characterization
  • Challenges with Bispecific & Higher Antibodies
  • Antibody Drug Conjugates
  • Alternate Host Cell Platforms
  • Cold-Chain Management
  • Pandemic Preparation
  • Lessons Learned & Emerging Best Practices
  • Developability Assessment & Sequence Liability
  • Antibody Lead Discovery
  • High Concentration Formulations
  • Prophylactic vs. Therapeutic Applications
Speakers
Register
Sponsorships
Workshops
Posters